Zherui Wu

Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer

Ludovic Fournel, Zherui Wu, Nicolas Städler et al. · Cancer Letters · 2019 · 259 citations

Medicine, Oncology, Pharmacology +16

MEF2C promotes M1 macrophage polarization and Th1 responses

Xibao Zhao, Qianqian Di, Han Liu et al. · Cellular and Molecular Immunology · 2022 · 129 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Zherui Wu, Jean Trédaniel, Patricia Forgez · Frontiers in Endocrinology · 2013 · 109 citations · Full text

Medicine, Oncology, Pharmacology +16

USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy

Qianqian Di, Xibao Zhao, Haimei Tang et al. · Autophagy · 2022 · 73 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib

Mohamad Younes, Zherui Wu, Sandra Dupouy et al. · Oncotarget · 2014 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +17